☰

cached image

Jeffrey L. Cummings, MD,University of Washington 1974 - Publications

Affiliations: 
Neurology University of California, Los Angeles, Los Angeles, CA 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=17
Website:
http://www.uclahealth.org/body.cfm?id=479&action=detail&ref=7535
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

220 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Cummings JL, Siffert J. Dextromethorphan-Quinidine for Agitation in Alzheimer Disease--Reply. Jama. 315: 1166-7. PMID 26978215 DOI: 10.1001/jama.2015.18289  0.32
2016 Cummings JL, Zhong K, Kinney JW, Heaney C, Moll-Tudla J, Joshi A, Pontecorvo M, Devous M, Tang A, Bena J. Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease. Alzheimer's Research & Therapy. 8: 4. PMID 26822146 DOI: 10.1186/s13195-016-0173-2  0.32
2015 Cummings JL, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW, De La Gandara JE, Agronin M, Davis CS, Nguyen U, Shin P, Tariot PN, Siffert J. Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial. Jama. 314: 1242-54. PMID 26393847 DOI: 10.1001/jama.2015.10214  0.32
2015 Grill JD, Raman R, Ernstrom K, Aisen P, Dowsett SA, Chen YF, Liu-Seifert H, Hake AM, Miller DS, Doody RS, Henley DB, Cummings JL. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials. Alzheimer's Research & Therapy. 7: 39. PMID 26120368 DOI: 10.1186/s13195-015-0122-5  0.32
2015 Yuan J, Zhang Z, Wen H, Hong X, Hong Z, Qu Q, Tang M, Wu J, Xu Q, Li H, Cummings JL. Incidence of dementia and subtypes: A cohort study in four regions in China. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26086181 DOI: 10.1016/j.jalz.2015.02.011  0.32
2015 Mao HF, Kuo CA, Huang WN, Cummings JL, Hwang TJ. Values of the Minimal Clinically Important Difference for the Neuropsychiatric Inventory Questionnaire in Individuals with Dementia. Journal of the American Geriatrics Society. 63: 1448-52. PMID 26046666 DOI: 10.1111/jgs.13473  0.32
2015 Molinuevo JL, Frölich L, Grossberg GT, Galvin JE, Cummings JL, Krahnke T, Strohmaier C. Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch. Alzheimer's Research & Therapy. 7: 9. PMID 25755685 DOI: 10.1186/s13195-014-0088-8  0.32
2015 Ringman JM, Liang LJ, Zhou Y, Vangala S, Teng E, Kremen S, Wharton D, Goate A, Marcus DS, Farlow M, Ghetti B, McDade E, Masters CL, Mayeux RP, Rossor M, ... ... Cummings JL, et al. Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network. Brain : a Journal of Neurology. 138: 1036-45. PMID 25688083 DOI: 10.1093/brain/awv004  0.32
2015 Alva G, Cummings JL, Galvin JE, Meng X, Velting DM. Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease. International Journal of Clinical Practice. 69: 518-30. PMID 25684069 DOI: 10.1111/ijcp.12621  0.32
2015 Vogel SJ, Banks SJ, Cummings JL, Miller JB. Concordance of the Montreal cognitive assessment with standard neuropsychological measures Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 1: 289-294. DOI: 10.1016/j.dadm.2015.05.002  0.32
2014 Cummings JL, Morstorf T, Zhong K. Alzheimer's disease drug-development pipeline: few candidates, frequent failures. Alzheimer's Research & Therapy. 6: 37. PMID 25024750 DOI: 10.1186/alzrt269  0.32
2014 Cummings JL, Tribanek M, Hoerr R. Sensitivity to change of composite and frequency scores of the neuropsychiatric inventory in mild cognitive impairment. International Psychogeriatrics / Ipa. 26: 1871-4. PMID 24990088 DOI: 10.1017/S1041610214001185  0.32
2014 Miller JB, Banks SJ, Léger GC, Cummings JL. Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes. Translational Neurodegeneration. 3: 12. PMID 24921043 DOI: 10.1186/2047-9158-3-12  0.32
2014 Pillai JA, Bonner-Jackson A, Walker E, Mourany L, Cummings JL. Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 38: 224-33. PMID 24903099 DOI: 10.1159/000362715  0.32
2014 Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, ... ... Cummings JL, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet. Neurology. 13: 614-29. PMID 24849862 DOI: 10.1016/S1474-4422(14)70090-0  0.32
2014 Cummings JL, Fine MJ, Grachev ID, Jarecke CR, Johnson MK, Kuo PH, Schaecher KL, Oberdorf JA, Rezak M, Riley DE, Truong D. Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan™). The American Journal of Managed Care. 20: S97-109. PMID 24773455  0.32
2014 McLaughlin PM, Wright MJ, Larocca M, Nguyen PT, Teng E, Apostolova LG, Ringman JM, Zhou Y, Cummings JL, Woo E. The "Alzheimer's type" profile of semantic clustering in amnestic mild cognitive impairment. Journal of the International Neuropsychological Society : Jins. 20: 402-12. PMID 24521694 DOI: 10.1017/S135561771400006X  0.32
2014 Cummings JL, Zhong K. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges. Expert Review of Clinical Pharmacology. 7: 161-5. PMID 24502586 DOI: 10.1586/17512433.2014.884923  0.32
2014 Apostolova LG, Di LJ, Duffy EL, Brook J, Elashoff D, Tseng CH, Fairbanks L, Cummings JL. Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 37: 315-26. PMID 24481207 DOI: 10.1159/000351009  0.32
2013 Appleby BS, Cummings JL. Discovering new treatments for Alzheimer's disease by repurposing approved medications. Current Topics in Medicinal Chemistry. 13: 2306-27. PMID 24059463 DOI: 10.2174/15680266113136660162  0.32
2013 Salmon DP, Ferris SH, Thomas RG, Sano M, Cummings JL, Sperling RA, Petersen RC, Aisen PS. Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly. Neuropsychology. 27: 391-401. PMID 23876113 DOI: 10.1037/a0032707  0.32
2013 Apostolova LG, Babakchanian S, Hwang KS, Green AE, Zlatev D, Chou YY, DeCarli C, Jack CR, Petersen RC, Aisen PS, Cummings JL, Toga AW, Thompson PM. Ventricular enlargement and its clinical correlates in the imaging cohort from the ADCS MCI donepezil/vitamin E study. Alzheimer Disease and Associated Disorders. 27: 174-81. PMID 23694947 DOI: 10.1097/WAD.0b013e3182677b3d  0.32
2013 Molinuevo JL, Cummings JL, Dubois B, Scheltens P. Medical Clinics of North America. Early diagnosis and intervention in predementia Alzheimer's disease. Preface. The Medical Clinics of North America. 97: xiii-xv. PMID 23642584 DOI: 10.1016/j.mcna.2013.01.003  0.32
2013 Pillai JA, Cummings JL. Clinical trials in predementia stages of Alzheimer disease. The Medical Clinics of North America. 97: 439-57. PMID 23642580 DOI: 10.1016/j.mcna.2013.01.002  0.32
2013 Cummings JL, Dubois B, Molinuevo JL, Scheltens P. International Work Group criteria for the diagnosis of Alzheimer disease. The Medical Clinics of North America. 97: 363-8. PMID 23642575 DOI: 10.1016/j.mcna.2013.01.001  0.32
2013 Sabbagh JJ, Kinney JW, Cummings JL. Alzheimer's disease biomarkers: correspondence between human studies and animal models. Neurobiology of Disease. 56: 116-30. PMID 23631871 DOI: 10.1016/j.nbd.2013.04.010  0.32
2013 Trzepacz PT, Saykin A, Yu P, Bhamditipati P, Sun J, Dennehy EB, Willis B, Cummings JL. Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 607-22. PMID 23602309 DOI: 10.1016/j.jagp.2012.10.027  0.32
2013 Lauterbach EC, Cummings JL, Kuppuswamy PS. Toward a more precise, clinically--informed pathophysiology of pathological laughing and crying. Neuroscience and Biobehavioral Reviews. 37: 1893-916. PMID 23518269 DOI: 10.1016/j.neubiorev.2013.03.002  0.32
2013 Cummings JL, Banks SJ, Gary RK, Kinney JW, Lombardo JM, Walsh RR, Zhong K. Alzheimer's disease drug development: translational neuroscience strategies. Cns Spectrums. 18: 128-38. PMID 23472637 DOI: 10.1017/S1092852913000023  0.32
2013 Cummings JL, Geldmacher D, Farlow M, Sabbagh M, Christensen D, Betz P. High-dose donepezil (23 mg/day) for the treatment of moderate and severe Alzheimer's disease: drug profile and clinical guidelines. Cns Neuroscience & Therapeutics. 19: 294-301. PMID 23462265 DOI: 10.1111/cns.12076  0.32
2013 Kim HJ, Kang SJ, Kim C, Kim GH, Jeon S, Lee JM, Oh SJ, Kim JS, Choe YS, Lee KH, Noh Y, Cho H, Yoon CW, Chin J, Cummings JL, et al. The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms: a study among patients with subcortical vascular cognitive impairments. Neurobiology of Aging. 34: 1913-20. PMID 23414669 DOI: 10.1016/j.neurobiolaging.2013.01.002  0.32
2013 Appleby BS, Nacopoulos D, Milano N, Zhong K, Cummings JL. A review: treatment of Alzheimer's disease discovered in repurposed agents. Dementia and Geriatric Cognitive Disorders. 35: 1-22. PMID 23307039 DOI: 10.1159/000345791  0.32
2013 Senanarong V, Harnphadungkit K, Poungvarin N, Vannasaeng S, Chongwisal S, Chakorn T, Jamjumrus P, Raksthaput A, Chaichanettee S, Aoonkaew N, Udompunthurak S, Doody RS, Cummings JL. The Dementia and Disability Project in Thai Elderly: rational, design, methodology and early results. Bmc Neurology. 13: 3. PMID 23305293 DOI: 10.1186/1471-2377-13-3  0.32
2013 Cummings JL, Ihl R, Herrschaft H, Hoerr R, Tribanek M. Sensitivity to change of composite and frequency scores of the Neuropsychiatric Inventory in mild to moderate dementia. International Psychogeriatrics / Ipa. 25: 431-8. PMID 23194852 DOI: 10.1017/S1041610212001974  0.32
2013 Boxer AL, Gold M, Huey E, Hu WT, Rosen H, Kramer J, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, ... ... Cummings JL, et al. The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 189-98. PMID 23062850 DOI: 10.1016/j.jalz.2012.03.003  0.32
2013 Braskie MN, Medina LD, Rodriguez-Agudelo Y, Geschwind DH, Macias-Islas MA, Thompson PM, Cummings JL, Bookheimer SY, Ringman JM. Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease. Human Brain Mapping. 34: 3308-19. PMID 22806961 DOI: 10.1002/hbm.22141  0.32
2013 Grill JD, Di L, Lu PH, Lee C, Ringman J, Apostolova LG, Chow N, Kohannim O, Cummings JL, Thompson PM, Elashoff D. Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative. Neurobiology of Aging. 34: 62-72. PMID 22503160 DOI: 10.1016/j.neurobiolaging.2012.03.006  0.32
2013 Sabbagh JJ, Kinney JW, Cummings JL. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications. Neurobiology of Aging. 34: 169-83. PMID 22464953 DOI: 10.1016/j.neurobiolaging.2012.02.027  0.32
2012 Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, ... ... Cummings JL, et al. Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimer's Research & Therapy. 4: 43. PMID 23107780 DOI: 10.1186/alzrt146  0.32
2012 Salloway S, Mintzer J, Cummings JL, Geldmacher D, Sun Y, Yardley J, Mackell J. Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease. American Journal of Alzheimer's Disease and Other Dementias. 27: 421-32. PMID 22930699 DOI: 10.1177/1533317512454708  0.32
2012 Cummings JL. Food for Thought: Souvenaid® in Mild Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 22776968 DOI: 10.3233/JAD-2012-121297  0.32
2012 Ringman JM, Elashoff D, Geschwind DH, Welsh BT, Gylys KH, Lee C, Cummings JL, Cole GM. Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype. Archives of Neurology. 69: 757-64. PMID 22689192 DOI: 10.1001/archneurol.2012.277  0.32
2012 Ringman JM, Fithian AT, Gylys K, Cummings JL, Coppola G, Elashoff D, Pratico D, Moskovitz J, Bitan G. Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations. Dementia and Geriatric Cognitive Disorders. 33: 219-25. PMID 22584618 DOI: 10.1159/000338546  0.32
2012 Ringman JM, Coppola G, Elashoff D, Rodriguez-Agudelo Y, Medina LD, Gylys K, Cummings JL, Cole GM. Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 33: 1-5. PMID 22343824 DOI: 10.1159/000335729  0.32
2012 Ringman JM, Schulman H, Becker C, Jones T, Bai Y, Immermann F, Cole G, Sokolow S, Gylys K, Geschwind DH, Cummings JL, Wan HI. Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations. Archives of Neurology. 69: 96-104. PMID 22232349 DOI: 10.1001/archneurol.2011.642  0.32
2012 Doody RS, Cummings JL, Farlow MR. Reviewing the role of donepezil in the treatment of Alzheimer's disease. Current Alzheimer Research. 9: 773-81. PMID 22175653 DOI: 10.2174/156720512802455412  0.32
2012 Walker Z, Cummings JL. [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 74-83. PMID 22024052 DOI: 10.1016/j.jalz.2011.08.003  0.32
2012 Braskie MN, Medina LD, Rodriguez-Agudelo Y, Geschwind DH, Macias-Islas MA, Cummings JL, Bookheimer SY, Ringman JM. Increased fMRI signal with age in familial Alzheimer's disease mutation carriers. Neurobiology of Aging. 33: 424.e11-21. PMID 21129823 DOI: 10.1016/j.neurobiolaging.2010.09.028  0.32
2012 Andrawis JP, Hwang KS, Green AE, Kotlerman J, Elashoff D, Morra JH, Cummings JL, Toga AW, Thompson PM, Apostolova LG. Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiology of Aging. 33: 856-66. PMID 20833446 DOI: 10.1016/j.neurobiolaging.2010.07.020  0.32
2011 Medina LD, Rodriguez-Agudelo Y, Geschwind DH, Gilbert PE, Liang LJ, Cummings JL, Ringman JM. Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 32: 188-92. PMID 22134129 DOI: 10.1159/000333023  0.32
2011 Cummings JL. Alzheimer's disease clinical trials: changing the paradigm. Current Psychiatry Reports. 13: 437-42. PMID 22052382 DOI: 10.1007/s11920-011-0234-y  0.32
2011 Apostolova LG, Hwang KS, Medina LD, Green AE, Braskie MN, Dutton RA, Lai J, Geschwind DH, Cummings JL, Thompson PM, Ringman JM. Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 32: 118-25. PMID 21952501 DOI: 10.1159/000330471  0.32
2011 Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR, Weiner MW, Thomas RG, Schneider LS, Tariot PN. Chronic divalproex sodium use and brain atrophy in Alzheimer disease. Neurology. 77: 1263-71. PMID 21917762 DOI: 10.1212/WNL.0b013e318230a16c  0.32
2011 Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain : a Journal of Neurology. 134: 3146-66. PMID 21810889 DOI: 10.1093/brain/awr177  0.32
2011 Cummings JL. Biomarkers in Alzheimer's disease drug development. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: e13-44. PMID 21550318 DOI: 10.1016/j.jalz.2010.06.004  0.32
2011 Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, ... ... Cummings JL, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics. 43: 436-41. PMID 21460841 DOI: 10.1038/ng.801  0.32
2011 Ringman JM, Medina LD, Braskie M, Rodriguez-Agudelo Y, Geschwind DH, Macias-Islas MA, Cummings JL, Bookheimer S. Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task. Cerebral Cortex (New York, N.Y. : 1991). 21: 877-83. PMID 20729396 DOI: 10.1093/cercor/bhq158  0.32
2011 Ault KA, Balon R, Barber K, Basha M, Becker P, Beckham JD, Bharath S, Blereau RP, Brady WJ, Bryan CS, Buckley RM, Calianno C, Caplan LS, Cardarelli R, Carnethon MR, ... ... Cummings JL, et al. Our thanks to reviewers in 2011 Consultant. 51: 872.  0.32
2010 Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, et al. Revising the definition of Alzheimer's disease: a new lexicon. The Lancet. Neurology. 9: 1118-27. PMID 20934914 DOI: 10.1016/S1474-4422(10)70223-4  0.32
2010 Teng E, Becker BW, Woo E, Cummings JL, Lu PH. Subtle deficits in instrumental activities of daily living in subtypes of mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 30: 189-97. PMID 20798539 DOI: 10.1159/000313540  0.32
2010 Teng E, Becker BW, Woo E, Knopman DS, Cummings JL, Lu PH. Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease. Alzheimer Disease and Associated Disorders. 24: 348-53. PMID 20592580 DOI: 10.1097/WAD.0b013e3181e2fc84  0.32
2010 Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR, Petersen RC, Aisen PS, Jagust WJ, Koeppe RA, et al. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiology of Aging. 31: 1284-303. PMID 20538372 DOI: 10.1016/j.neurobiolaging.2010.05.003  0.32
2010 Cummings JL, Ferris SH, Farlow MR, Olin JT, Meng X. Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis. Dementia and Geriatric Cognitive Disorders. 29: 406-12. PMID 20502014 DOI: 10.1159/000296073  0.32
2010 Cummings JL. Integrating ADNI results into Alzheimer's disease drug development programs. Neurobiology of Aging. 31: 1481-92. PMID 20447734 DOI: 10.1016/j.neurobiolaging.2010.03.016  0.32
2010 Apostolova LG, Beyer M, Green AE, Hwang KS, Morra JH, Chou YY, Avedissian C, Aarsland D, Janvin CC, Larsen JP, Cummings JL, Thompson PM. Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 687-95. PMID 20437538 DOI: 10.1002/mds.22799  0.32
2010 Grill JD, Cummings JL. Current therapeutic targets for the treatment of Alzheimer's disease. Expert Review of Neurotherapeutics. 10: 711-28. PMID 20420492 DOI: 10.1586/ern.10.29  0.32
2010 Cummings JL. Commentary on: L-methylfolate, methylcobolamine, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline. Cns Spectrums. 15: 7. PMID 20397370  0.32
2010 Farlow MR, Cummings JL, Olin JT, Meng X. Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer's disease. American Journal of Alzheimer's Disease and Other Dementias. 25: 347-52. PMID 20392862 DOI: 10.1177/1533317510365344  0.32
2010 Faux NG, Ritchie CW, Gunn A, Rembach A, Tsatsanis A, Bedo J, Harrison J, Lannfelt L, Blennow K, Zetterberg H, Ingelsson M, Masters CL, Tanzi RE, Cummings JL, Herd CM, et al. PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. Journal of Alzheimer's Disease : Jad. 20: 509-16. PMID 20164561 DOI: 10.3233/JAD-2010-1390  0.32
2010 Apostolova LG, Thompson PM, Green AE, Hwang KS, Zoumalan C, Jack CR, Harvey DJ, Petersen RC, Thal LJ, Aisen PS, Toga AW, Cummings JL, Decarli CS. 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Human Brain Mapping. 31: 786-97. PMID 20143386 DOI: 10.1002/hbm.20905  0.32
2010 Cummings JL, Ringman J, Metz K. Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative. Journal of Alzheimer's Disease : Jad. 19: 375-88. PMID 20110588 DOI: 10.3233/JAD-2010-1286  0.32
2010 Apostolova LG, Morra JH, Green AE, Hwang KS, Avedissian C, Woo E, Cummings JL, Toga AW, Jack CR, Weiner MW, Thompson PM. Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage. 51: 488-99. PMID 20083211 DOI: 10.1016/j.neuroimage.2009.12.125  0.32
2010 Cummings JL, Farlow MR, Meng X, Tekin S, Olin JT. Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease. Clinical Drug Investigation. 30: 41-9. PMID 19995097 DOI: 10.2165/11531270-000000000-00000  0.32
2010 Apostolova LG, Thompson PM, Rogers SA, Dinov ID, Zoumalan C, Steiner CA, Siu E, Green AE, Small GW, Toga AW, Cummings JL, Phelps ME, Silverman DH. Surface feature-guided mapping of cerebral metabolic changes in cognitively normal and mildly impaired elderly. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 12: 218-24. PMID 19636640 DOI: 10.1007/s11307-009-0247-7  0.32
2010 Harvey PD, Ferris SH, Cummings JL, Wesnes KA, Hsu C, Lane RM, Tekin S. Evaluation of dementia rating scales in Parkinson's disease dementia. American Journal of Alzheimer's Disease and Other Dementias. 25: 142-8. PMID 19359706 DOI: 10.1177/1533317509333904  0.32
2010 Lu PH, Khanlou N, Cummings JL. Frontotemporal dementia and the orbitofrontal cortex The Orbitofrontal Cortex. 1-26. DOI: 10.1093/acprof:oso/9780198565741.003.0024  0.32
2010 Cummings JL. The clinical approach to the person with dementia: The United States of America Dementia: a Global Approach. 137-140. DOI: 10.1017/CBO9780511780615.018  0.32
2010 Senanarong V, Cummings JL. Assessment: Assessing behavior in dementia across cultures Dementia: a Global Approach. 73-86. DOI: 10.1017/CBO9780511780615.009  0.32
2010 Krishnamoorthy ES, Prince MJ, Cummings JL. Dementia: A global approach Dementia: a Global Approach. 1-202. DOI: 10.1017/CBO9780511780615  0.32
2009 Fuh JL, Cummings JL. Top cited papers in International Psychogeriatrics: 6b. Behavioral disorders and caregivers' reaction in Taiwanese patients with Alzheimer's disease. International Psychogeriatrics / Ipa. 21: 1031-6. PMID 19781110 DOI: 10.1017/S1041610209990913  0.32
2009 Cummings JL. Defining and labeling disease-modifying treatments for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 406-18. PMID 19751920 DOI: 10.1016/j.jalz.2008.12.003  0.32
2009 Teng E, Tingus KD, Lu PH, Cummings JL. Persistence of neuropsychological testing deficits in mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 28: 168-78. PMID 19707017 DOI: 10.1159/000235732  0.32
2009 Ringman JM, Medina LD, Rodriguez-Agudelo Y, Chavez M, Lu P, Cummings JL. Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease. Current Alzheimer Research. 6: 341-6. PMID 19689233 DOI: 10.2174/156720509788929336  0.32
2009 Chow TW, Binns MA, Cummings JL, Lam I, Black SE, Miller BL, Freedman M, Stuss DT, van Reekum R. Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type. Archives of Neurology. 66: 888-93. PMID 19597092 DOI: 10.1001/archneurol.2009.92  0.32
2009 Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology. 72: 2115-21. PMID 19528519 DOI: 10.1212/WNL.0b013e3181aa52d3  0.32
2009 Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, Robert P, Lyketsos CG. Management of agitation and aggression associated with Alzheimer disease. Nature Reviews. Neurology. 5: 245-55. PMID 19488082 DOI: 10.1038/nrneurol.2009.39  0.32
2009 Cummings JL. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Establishing a national biomarker database: utility and incentives. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 108-13. PMID 19328437 DOI: 10.1016/j.jalz.2009.01.015  0.32
2009 Saint-Cyr JA, Bronstein YL, Cummings JL. Neurobehavioral Consequences of Neurosurgical Treatments and Focal Lesions of Frontal-Subcortical Circuits Principles of Frontal Lobe Function. DOI: 10.1093/acprof:oso/9780195134971.003.0026  0.32
2009 Teng E, Marshall GA, Cummings JL. Neuropsychiatric features of dementia The Behavioral Neurology of Dementia. 85-100. DOI: 10.1017/CBO9780511581410.007  0.32
2008 Connor DJ, Sabbagh MN, Cummings JL. Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 390-4. PMID 19012863 DOI: 10.1016/j.jalz.2008.09.002  0.32
2008 Cummings JL. Integrating symptomatic- and disease-modifying treatments. Cns Spectrums. 13: 28-30. PMID 18955958  0.32
2008 Cummings JL. Introduction Cns Spectrums. 13: 4-5. PMID 18955947 DOI: 10.1016/S1098-3597(01)90043-2  0.32
2008 Cummings JL. Controversies in Alzheimer's disease drug development. International Review of Psychiatry (Abingdon, England). 20: 389-95. PMID 18925488 DOI: 10.1080/09540260802094548  0.32
2008 Schaffer BA, Bertram L, Miller BL, Mullin K, Weintraub S, Johnson N, Bigio EH, Mesulam M, Wiedau-Pazos M, Jackson GR, Cummings JL, Cantor RM, Levey AI, Tanzi RE, Geschwind DH. Association of GSK3B with Alzheimer disease and frontotemporal dementia. Archives of Neurology. 65: 1368-74. PMID 18852354 DOI: 10.1001/archneur.65.10.1368  0.32
2008 Cummings JL. Optimizing phase II of drug development for disease-modifying compounds. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: S15-20. PMID 18631992 DOI: 10.1016/j.jalz.2007.10.002  0.32
2008 Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, ... ... Cummings JL, et al. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 156-63. PMID 18631960 DOI: 10.1016/j.jalz.2008.03.005  0.32
2008 Salloway S, Mintzer J, Weiner MF, Cummings JL. Disease-modifying therapies in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 65-79. PMID 18631951 DOI: 10.1016/j.jalz.2007.10.001  0.32
2008 Cummings JL, Mackell J, Kaufer D. Behavioral effects of current Alzheimer's disease treatments: a descriptive review. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 49-60. PMID 18631950 DOI: 10.1016/j.jalz.2007.10.011  0.32
2008 Fillit HM, Simon ES, Doniger GM, Cummings JL. Practicality of a computerized system for cognitive assessment in the elderly. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 14-21. PMID 18631946 DOI: 10.1016/j.jalz.2007.09.008  0.32
2008 Marshall GA, Cummings JL. Neuropsychiatric evaluation in dementia. Handbook of Clinical Neurology. 89: 53-61. PMID 18631730 DOI: 10.1016/S0072-9752(07)01204-3  0.32
2008 Teng E, Ringman JM, Ross LK, Mulnard RA, Dick MB, Bartzokis G, Davies HD, Galasko D, Hewett L, Mungas D, Reed BR, Schneider LS, Segal-Gidan F, Yaffe K, Cummings JL, et al. Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 469-77. PMID 18515691 DOI: 10.1097/JGP.0b013e318165dbae  0.32
2008 Ringman JM, Younkin SG, Pratico D, Seltzer W, Cole GM, Geschwind DH, Rodriguez-Agudelo Y, Schaffer B, Fein J, Sokolow S, Rosario ER, Gylys KH, Varpetian A, Medina LD, Cummings JL. Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology. 71: 85-92. PMID 18509095 DOI: 10.1212/01.wnl.0000303973.71803.81  0.32
2008 Ringman JM, Romano JD, Medina LD, Rodriguez-Agudelo Y, Schaffer B, Varpetian A, Ortiz F, Fitten LJ, Cummings JL, Baloh RW. Increased prevalence of significant recurrent headache in preclinical familial Alzheimer's disease mutation carriers. Dementia and Geriatric Cognitive Disorders. 25: 380-4. PMID 18376127 DOI: 10.1159/000121986  0.32
2008 Bonelli RM, Cummings JL. Frontal-subcortical dementias. The Neurologist. 14: 100-7. PMID 18332839 DOI: 10.1097/NRL.0b013e31815b0de2  0.32
2008 Cummings JL, Miller BL, Christensen DD, Cherry D. Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease. Cns Spectrums. 13: 1-20; quiz 22. PMID 18264030  0.32
2008 Apostolova LG, Cummings JL. Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dementia and Geriatric Cognitive Disorders. 25: 115-26. PMID 18087152 DOI: 10.1159/000112509  0.32
2008 Apostolova LG, Lu P, Rogers S, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM. 3D mapping of language networks in clinical and pre-clinical Alzheimer's disease. Brain and Language. 104: 33-41. PMID 17485107 DOI: 10.1016/j.bandl.2007.03.008  0.32
2008 Tsang SW, Vinters HV, Cummings JL, Wong PT, Chen CP, Lai MK. Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease. Neurobiology of Aging. 29: 1524-32. PMID 17433503 DOI: 10.1016/j.neurobiolaging.2007.03.014  0.32
2008 Cummings JL. Progress in neurotherapeutics and neuropsychopharmacology 2008 Progress in Neurotherapeutics and Neuropsychopharmacology. 3: 1-11. DOI: 10.1017/S1748232107000183  0.32
2008 Cummings JL. Primary Psychiatry: Introduction Primary Psychiatry. 15: 4-5.  0.32
2008 Cummings JL. Integrating symptomatic-and disease-modifying treatments Primary Psychiatry. 15: 28-30.  0.32
2008 Cummings JL. Update on Alzheimer's disease: One hundred years after Dr. Alois Alzheimer Primary Psychiatry. 15: 4-6.  0.32
2008 Cummings JL. The black book of Alzheimer's disease, part 1 Primary Psychiatry. 15: 66-76.  0.32
2007 Cummings JL, Jeste DV. Pharmacotherapy of neuropsychiatric syndromes in neurologic disorders: definitional and regulatory aspects. Psychopharmacology Bulletin. 40: 89-98. PMID 18227780  0.32
2007 Cummings JL, Doody R, Clark C. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology. 69: 1622-34. PMID 17938373 DOI: 10.1212/01.wnl.0000295996.54210.69  0.32
2007 Apostolova LG, Steiner CA, Akopyan GG, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM. Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. Archives of Neurology. 64: 1489-95. PMID 17923632 DOI: 10.1001/archneur.64.10.1489  0.32
2007 Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J, Hubbard JL, Koepsell TD, Morris JC, Kukull WA, Reiman EM, Kowall N, Landreth G, Shelanski M, Welsh-Bohmer K, ... ... Cummings JL, et al. The National Alzheimer's Coordinating Center (NACC) database: The uniform data set Alzheimer Disease and Associated Disorders. 21: 249-258. PMID 17804958 DOI: 10.1097/WAD.0b013e318142774e  0.32
2007 Bonelli RM, Cummings JL. Frontal-subcortical circuitry and behavior. Dialogues in Clinical Neuroscience. 9: 141-51. PMID 17726913  0.32
2007 Teng E, Lu PH, Cummings JL. Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 24: 253-9. PMID 17700021 DOI: 10.1159/000107100  0.32
2007 Emre M, Cummings JL, Lane RM. Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences. Journal of Alzheimer's Disease : Jad. 11: 509-19. PMID 17656830  0.32
2007 Marshall GA, Monserratt L, Harwood D, Mandelkern M, Cummings JL, Sultzer DL. Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Archives of Neurology. 64: 1015-20. PMID 17620493 DOI: 10.1001/archneur.64.7.1015  0.32
2007 Apostolova LG, Akopyan GG, Partiali N, Steiner CA, Dutton RA, Hayashi KM, Dinov ID, Toga AW, Cummings JL, Thompson PM. Structural correlates of apathy in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 24: 91-7. PMID 17570907 DOI: 10.1159/000103914  0.32
2007 Ringman JM, O'Neill J, Geschwind D, Medina L, Apostolova LG, Rodriguez Y, Schaffer B, Varpetian A, Tseng B, Ortiz F, Fitten J, Cummings JL, Bartzokis G. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain : a Journal of Neurology. 130: 1767-76. PMID 17522104 DOI: 10.1093/brain/awm102  0.32
2007 Farlow MR, Cummings JL. Effective pharmacologic management of Alzheimer's disease. The American Journal of Medicine. 120: 388-97. PMID 17466645 DOI: 10.1016/j.amjmed.2006.08.036  0.32
2007 Cummings JL. Involuntary emotional expression disorder: definition, diagnosis, and measurement scales. Cns Spectrums. 12: 11-6. PMID 17426670  0.32
2007 Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL. Early-onset Alzheimer's disease is associated with greater pathologic burden. Journal of Geriatric Psychiatry and Neurology. 20: 29-33. PMID 17341768 DOI: 10.1177/0891988706297086  0.32
2007 Tsang SW, Pomakian J, Marshall GA, Vinters HV, Cummings JL, Chen CP, Wong PT, Lai MK. Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease. Neurobiology of Aging. 28: 1381-7. PMID 16828202 DOI: 10.1016/j.neurobiolaging.2006.06.001  0.32
2007 Aarsland D, Brønnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, Cummings JL. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 36-42. PMID 16820421 DOI: 10.1136/jnnp.2005.083113  0.32
2007 Cummings JL. The neuropsychiatric disturbances in demential disorders or behavioral and psychological symptoms of dementia Jornal Brasileiro De Psiquiatria. 56: 81-82. DOI: 10.1590/S0047-20852007000200001  0.32
2007 Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Appendix C: Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology Continuum Lifelong Learning in Neurology. 13: 222-231. DOI: 10.1212/01.CON.0000267233.84626.08  0.32
2007 Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC. Appendix B: Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology Continuum Lifelong Learning in Neurology. 13: 210-221. DOI: 10.1212/01.CON.0000267232.84626.41  0.32
2007 Marshall GA, Cummings JL. Chapter 16 Behavioral Syndromes and Their Treatment Blue Books of Neurology. 30: 411-427. DOI: 10.1016/S1877-184X(09)70067-X  0.32
2007 Marshall GA, Cummings JL. Affective Disorders Neurology and Clinical Neuroscience. 235-247. DOI: 10.1016/B978-0-323-03354-1.50023-7  0.32
2006 Tractenberg RE, Aisen PS, Weiner MF, Cummings JL, Hancock GR. Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 303-13. PMID 19595904 DOI: 10.1016/j.jalz.2006.08.001  0.32
2006 Salmon DP, Cummings JL, Jin S, Sano M, Sperling RA, Zamrini E, Petersen RC, Edland SD, Thal LJ, Ferris SH. ADCS Prevention Instrument Project: development of a brief verbal memory test for primary prevention clinical trials. Alzheimer Disease and Associated Disorders. 20: S139-46. PMID 17135807 DOI: 10.1097/01.wad.0000213871.40300.68  0.32
2006 Morris JC, Cummings JL. Workshop reports from the third Asia-pacific regional meeting of the international working group on harmonization of dementia drug guidelines. Alzheimer Disease and Associated Disorders. 20: 313. PMID 17132980 DOI: 10.1097/01.wad.0000213868.94558.10  0.32
2006 Apostolova LG, Dinov ID, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain : a Journal of Neurology. 129: 2867-73. PMID 17018552 DOI: 10.1093/brain/awl274  0.32
2006 Ortiz F, Fitten LJ, Cummings JL, Hwang S, Fonseca M. Neuropsychiatric and behavioral symptoms in a community sample of Hispanics with Alzheimer's disease. American Journal of Alzheimer's Disease and Other Dementias. 21: 263-73. PMID 16948291 DOI: 10.1177/1533317506289350  0.32
2006 Apostolova LG, Klement I, Bronstein Y, Vinters HV, Cummings JL. Multiple system atrophy presenting with language impairment. Neurology. 67: 726-7. PMID 16924041 DOI: 10.1212/01.wnl.0000230136.82118.16  0.32
2006 Murrell J, Ghetti B, Cochran E, Macias-Islas MA, Medina L, Varpetian A, Cummings JL, Mendez MF, Kawas C, Chui H, Ringman JM. The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families. Neurogenetics. 7: 277-9. PMID 16897084 DOI: 10.1007/s10048-006-0053-1  0.32
2006 Cummings JL, Arciniegas DB, Brooks BR, Herndon RM, Lauterbach EC, Pioro EP, Robinson RG, Scharre DW, Schiffer RB, Weintraub D. Defining and diagnosing involuntary emotional expression disorder. Cns Spectrums. 11: 1-7. PMID 16816786  0.32
2006 Ringman JM, Cummings JL. Current and emerging pharmacological treatment options for dementia. Behavioural Neurology. 17: 5-16. PMID 16720956  0.32
2006 Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Archives of Neurology. 63: 693-9. PMID 16682538 DOI: 10.1001/archneur.63.5.693  0.32
2006 Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, et al. Mild cognitive impairment. Lancet. 367: 1262-70. PMID 16631882 DOI: 10.1016/S0140-6736(06)68542-5  0.32
2006 Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL. Neuropathologic correlates of activities of daily living in Alzheimer disease. Alzheimer Disease and Associated Disorders. 20: 56-9. PMID 16493237 DOI: 10.1097/01.wad.0000201852.60330.16  0.32
2006 Cummings JL, Zhong K. Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies. Nature Reviews. Drug Discovery. 5: 64-74. PMID 16485346 DOI: 10.1038/nrd1928  0.32
2006 Kepe V, Barrio JR, Huang SC, Ercoli L, Siddarth P, Shoghi-Jadid K, Cole GM, Satyamurthy N, Cummings JL, Small GW, Phelps ME. Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proceedings of the National Academy of Sciences of the United States of America. 103: 702-7. PMID 16407119 DOI: 10.1073/pnas.0510237103  0.32
2006 Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL. Neuropathologic correlates of apathy in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 21: 144-7. PMID 16391476 DOI: 10.1159/000090674  0.32
2005 Cummings JL, Altman J. Genotype, proteotype, phenotype relationships in neurodegenerative diseases. Highlights from the 21st Ipsen Foundation Alzheimer's Disease Symposium, September 13, 2004, Paris, France. Reviews in Neurological Diseases. 2: 80-4. PMID 19813301  0.32
2005 Cummings JL, Koumaras B, Chen M, Mirski D. Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study. The American Journal of Geriatric Pharmacotherapy. 3: 137-48. PMID 16257816 DOI: 10.1016/S1543-5946(05)80020-0  0.32
2005 Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL. A potential role of the curry spice curcumin in Alzheimer's disease. Current Alzheimer Research. 2: 131-6. PMID 15974909 DOI: 10.2174/1567205053585882  0.32
2005 Mega MS, Dinov ID, Porter V, Chow G, Reback E, Davoodi P, O'Connor SM, Carter MF, Amezcua H, Cummings JL. Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study. Archives of Neurology. 62: 721-8. PMID 15883258 DOI: 10.1001/archneur.62.5.721  0.32
2005 Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 53: 695-9. PMID 15817019 DOI: 10.1111/j.1532-5415.2005.53221.x  0.32
2005 Tractenberg RE, Weiner MF, Cummings JL, Patterson MB, Thal LJ. Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach. The Journal of Neuropsychiatry and Clinical Neurosciences. 17: 51-60. PMID 15746483 DOI: 10.1176/appi.neuropsych.17.1.51  0.32
2004 Cummings JL. Treatment of Alzheimer's disease: current and future therapeutic approaches. Reviews in Neurological Diseases. 1: 60-9. PMID 16400259  0.32
2004 Cummings JL. Reconsidering diagnostic criteria for dementia with lewy bodies. Highlights from the Third International Workshop on Dementia with Lewy Bodies and Parkinson's Disease Dementia, September 17-20, 2003, Newcastle Upon Tyne, United Kingdom. Reviews in Neurological Diseases. 1: 31-4. PMID 16397449  0.32
2004 Cummings JL, Tractenberg RE, Gamst A, Teri L, Masterman D, Thal LJ. Regression to the mean: implications for clinical trials of psychotropic agents in dementia. Current Alzheimer Research. 1: 323-8. PMID 15975061  0.32
2004 Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiology of Aging. 25: 843-51. PMID 15212838 DOI: 10.1016/j.neurobiolaging.2003.09.005  0.32
2004 Bartzokis G, Tishler TA, Shin IS, Lu PH, Cummings JL. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Annals of the New York Academy of Sciences. 1012: 224-36. PMID 15105269 DOI: 10.1196/annals.1306.019  0.32
2004 Waltz JA, Knowlton BJ, Holyoak KJ, Boone KB, Back-Madruga C, McPherson S, Masterman D, Chow T, Cummings JL, Miller BL. Relational integration and executive function in Alzheimer's disease. Neuropsychology. 18: 296-305. PMID 15099152 DOI: 10.1037/0894-4105.18.2.296  0.32
2004 Swanberg MM, Tractenberg RE, Mohs R, Thal LJ, Cummings JL. Executive dysfunction in Alzheimer disease. Archives of Neurology. 61: 556-60. PMID 15096405 DOI: 10.1001/archneur.61.4.556  0.32
2004 Kang SJ, Choi SH, Lee BH, Jeong Y, Hahm DS, Han IW, Cummings JL, Na DL. Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI). Journal of Geriatric Psychiatry and Neurology. 17: 32-5. PMID 15018695 DOI: 10.1177/089198873258818  0.32
2004 Cummings JL, Schneider L, Tariot PN, Kershaw PR, Yuan W. Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease. The American Journal of Psychiatry. 161: 532-8. PMID 14992980 DOI: 10.1176/appi.ajp.161.3.532  0.32
2004 Fu C, Chute DJ, Farag ES, Garakian J, Cummings JL, Vinters HV. Comorbidity in dementia: an autopsy study. Archives of Pathology & Laboratory Medicine. 128: 32-8. PMID 14692815 DOI: 10.1043/1543-2165(2004)128<32:CID>2.0.CO;2  0.32
2003 Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC, Bruce ML, Caine ED, Cummings JL, Devanand DP, Jeste DV, Krishnan KR, Lyketsos CG, Lyness JM, Rabins PV, et al. Provisional diagnostic criteria for depression of Alzheimer's disease: description and review. Expert Review of Neurotherapeutics. 3: 99-106. PMID 19810852 DOI: 10.1586/14737175.3.1.99  0.32
2003 Silverman DH, Truong CT, Kim SK, Chang CY, Chen W, Kowell AP, Cummings JL, Czernin J, Small GW, Phelps ME. Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Molecular Genetics and Metabolism. 80: 350-5. PMID 14680983 DOI: 10.1016/S1096-7192(03)00139-2  0.32
2003 Tractenberg RE, Singer CM, Cummings JL, Thal LJ. The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease. Journal of Sleep Research. 12: 331-7. PMID 14633245  0.32
2003 Mendez MF, Clark DG, Shapira JS, Cummings JL. Speech and language in progressive nonfluent aphasia compared with early Alzheimer's disease. Neurology. 61: 1108-13. PMID 14581673 DOI: 10.1016/B978-141603618-0.10006-2  0.32
2003 Solomon DH, Wenger NS, Saliba D, Young RT, Adelman AM, Besdine RK, Blazer DG, Cassell CK, Cummings JL, Katz PR, Kitzman DW, Lavizzo-Mourey RJ, Mondoux LC, Popovich R, Pories WJ, et al. Appropriateness of quality indicators for older patients with advanced dementia and poor prognosis. Journal of the American Geriatrics Society. 51: 902-7. PMID 12834508 DOI: 10.1046/j.1365-2389.2003.513331.x  0.32
2003 Sobrido MJ, Miller BL, Havlioglu N, Zhukareva V, Jiang Z, Nasreddine ZS, Lee VM, Chow TW, Wilhelmsen KC, Cummings JL, Wu JY, Geschwind DH. Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia. Archives of Neurology. 60: 698-702. PMID 12756133 DOI: 10.1001/archneur.60.5.698  0.32
2003 Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR, Smith GE, Geda YE, Cummings JL, Petersen RC, Sunderland T. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. The American Journal of Psychiatry. 160: 857-66. PMID 12727688 DOI: 10.1176/appi.ajp.160.5.857  0.32
2003 Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Archives of Neurology. 60: 393-8. PMID 12633151 DOI: 10.1001/archneur.60.3.393  0.32
2003 Sobrido MJ, Abu-Khalil A, Weintraub S, Johnson N, Quinn B, Cummings JL, Mesulam MM, Geschwind DH. Possible association of the tau H1/H1 genotype with primary progressive aphasia. Neurology. 60: 862-4. PMID 12629248  0.32
2003 Sultzer DL, Brown CV, Mandelkern MA, Mahler ME, Mendez MF, Chen ST, Cummings JL. Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. The American Journal of Psychiatry. 160: 341-9. PMID 12562582 DOI: 10.1176/appi.ajp.160.2.341  0.32
2002 Silverman DH, Cummings JL, Small GW, Gambhir SS, Chen W, Czernin J, Phelps ME. Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 4: 283-93. PMID 14537119 DOI: 10.1016/S1536-1632(02)00016-1  0.32
2002 Chow TW, Miller BL, Boone K, Mishkin F, Cummings JL. Frontotemporal dementia classification and neuropsychiatry. The Neurologist. 8: 263-9. PMID 12803685  0.32
2002 Royall DR, Lauterbach EC, Cummings JL, Reeve A, Rummans TA, Kaufer DI, LaFrance WC, Coffey CE. Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 377-405. PMID 12426407 DOI: 10.1176/appi.neuropsych.14.4.377  0.32
2002 Sultzer DL, Chen ST, Brown CV, Mahler ME, Cummings JL, Hinkin CH, Mandelkern MA. Subcortical hyperintensities in Alzheimer's disease: associated clinical and metabolic findings. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 262-9. PMID 12154149 DOI: 10.1176/appi.neuropsych.14.3.262  0.32
2002 Rosen HJ, Hartikainen KM, Jagust W, Kramer JH, Reed BR, Cummings JL, Boone K, Ellis W, Miller C, Miller BL. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology. 58: 1608-15. PMID 12058087  0.32
2002 Ringman JM, Diaz-Olavarrieta C, Rodriguez Y, Fairbanks L, Cummings JL. The prevalence and correlates of neuropsychiatric symptoms in a population with Parkinson's disease in Mexico. Neuropsychiatry, Neuropsychology, and Behavioral Neurology. 15: 99-105. PMID 12050472  0.32
2002 Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC, Bruce ML, Caine ED, Cummings JL, Devanand DP, Krishnan KR, Lyketsos CG, Lyness JM, Rabins PV, Reynolds CF, et al. Provisional diagnostic criteria for depression of Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 10: 125-8. PMID 11925273 DOI: 10.1097/00019442-200203000-00003  0.32
2002 Cummings JL, Street J, Masterman D, Clark WS. Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies. Dementia and Geriatric Cognitive Disorders. 13: 67-73. PMID 11844887 DOI: 10.1159/000048636  0.32
2002 Pang FC, Chow TW, Cummings JL, Leung VP, Chiu HF, Lam LC, Chen QL, Tai CT, Chen LW, Wang SJ, Fuh JL. Effect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers. International Journal of Geriatric Psychiatry. 17: 29-34. PMID 11802227 DOI: 10.1002/gps.510  0.32
2002 Chow TW, Liu CK, Fuh JL, Leung VP, Tai CT, Chen LW, Wang SJ, Chiu HF, Lam LC, Chen QL, Cummings JL. Neuropsychiatric symptoms of Alzheimer's disease differ in Chinese and American patients. International Journal of Geriatric Psychiatry. 17: 22-8. PMID 11802226 DOI: 10.1002/gps.509  0.32
2001 Geschwind DH, Robidoux J, Alarcón M, Miller BL, Wilhelmsen KC, Cummings JL, Nasreddine ZS. Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Annals of Neurology. 50: 741-6. PMID 11761471 DOI: 10.1002/ana.10024  0.32
2001 Kulisevsky J, Litvan I, Berthier ML, Pascual-Sedano B, Paulsen JS, Cummings JL. Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 1098-104. PMID 11748741 DOI: 10.1002/mds.1225  0.32
2001 Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, Welsh-Bohmer KA, Alavi A, ... ... Cummings JL, et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. Jama. 286: 2120-7. PMID 11694153  0.32
2001 Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL. Neuropsychiatric aspects of Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 71: 310-4. PMID 11511702 DOI: 10.1136/jnnp.71.3.310  0.32
2001 Cummings JL, Nadel A, Masterman D, Cyrus PA. Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 14: 101-8. PMID 11419566  0.32
2001 Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 56: 1154-66. PMID 11342679  0.32
2001 Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 56: 1143-53. PMID 11342678  0.32
2001 Tekin S, Mega MS, Masterman DM, Chow T, Garakian J, Vinters HV, Cummings JL. Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Annals of Neurology. 49: 355-61. PMID 11261510 DOI: 10.1002/ana.72  0.32
2001 Mega MS, Cummings JL, O'Connor SM, Dinov ID, Reback E, Felix J, Masterman DL, Phelps ME, Small GW, Toga AW. Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease. Neuropsychiatry, Neuropsychology, and Behavioral Neurology. 14: 63-8. PMID 11234910  0.32
2000 Cummings JL. Cholinesterase inhibitors: expanding applications. Lancet. 356: 2024-5. PMID 11145482 DOI: 10.1016/S0140-6736(00)03393-6  0.32
2000 Cummings JL. New tests for dementia. Neurology. 55: 1601-2. PMID 11113211  0.32
2000 Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, Ballard CG. The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. The British Journal of Psychiatry : the Journal of Mental Science. 177: 252-6. PMID 11040887 DOI: 10.1192/bjp.177.3.252  0.32
2000 Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD, Breier A. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Archives of General Psychiatry. 57: 968-76. PMID 11015815  0.32
2000 Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. The Journal of Neuropsychiatry and Clinical Neurosciences. 12: 233-9. PMID 11001602 DOI: 10.1176/appi.neuropsych.12.2.233  0.32
2000 Mega MS, Dinov ID, Lee L, O'Connor SM, Masterman DM, Wilen B, Mishkin F, Toga AW, Cummings JL. Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 12: 209-18. PMID 11001599 DOI: 10.1176/appi.neuropsych.12.2.209  0.32
2000 Chow TW, Ross L, Fox P, Cummings JL, Lin KM. Utilization of Alzheimer's disease community resources by Asian-Americans in California. International Journal of Geriatric Psychiatry. 15: 838-47. PMID 10984731 DOI: 10.1002/1099-1166(200009)15:9<838::AID-GPS209>3.0.CO;2-U  0.32
2000 Lindau M, Almkvist O, Kushi J, Boone K, Johansson SE, Wahlund LO, Cummings JL, Miller BL. First symptoms--frontotemporal dementia versus Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 11: 286-93. PMID 10940680  0.32
2000 Miller BL, Boone K, Cummings JL, Read SL, Mishkin F. Functional correlates of musical and visual ability in frontotemporal dementia. The British Journal of Psychiatry : the Journal of Mental Science. 176: 458-63. PMID 10912222 DOI: 10.1192/bjp.176.5.458  0.32
2000 Mega MS, Lee L, Dinov ID, Mishkin F, Toga AW, Cummings JL. Cerebral correlates of psychotic symptoms in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 69: 167-71. PMID 10896687 DOI: 10.1136/jnnp.69.2.167  0.32
2000 Hirono N, Mega MS, Dinov ID, Mishkin F, Cummings JL. Left frontotemporal hypoperfusion is associated with aggression in patients with dementia. Archives of Neurology. 57: 861-6. PMID 10867784  0.32
2000 Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, Mazziotta JC, Saxena S, Wu HM, Mega MS, Cummings JL, et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 97: 6037-42. PMID 10811879 DOI: 10.1073/pnas.090106797  0.32
2000 Cummings JL, Donohue JA, Brooks RL. The relationship between donepezil and behavioral disturbances in patients with Alzheimer's disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 8: 134-40. PMID 10804074 DOI: 10.1097/00019442-200005000-00008  0.32
2000 Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, Ballard CG. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology. 54: 1616-25. PMID 10762503  0.32
2000 Cummings JL. A window on the role of dopamine in addiction disorders. Journal of Neurology, Neurosurgery, and Psychiatry. 68: 404. PMID 10727473 DOI: 10.1136/jnnp.68.4.404  0.32
2000 Cummings JL, Litvan I. Neuropsychiatric aspects of corticobasal degeneration. Advances in Neurology. 82: 147-52. PMID 10624478  0.32
1999 Ringman JM, Cummings JL. Metrifonate (Trichlorfon): a review of the pharmacology, pharmacokinetics and clinical experience with a new acetylcholinesterase inhibitor for Alzheimer's disease. Expert Opinion On Investigational Drugs. 8: 463-71. PMID 15992092 DOI: 10.1517/13543784.8.4.463  0.32
1999 Jeste DV, Alexopoulos GS, Bartels SJ, Cummings JL, Gallo JJ, Gottlieb GL, Halpain MC, Palmer BW, Patterson TL, Reynolds CF, Lebowitz BD. Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Archives of General Psychiatry. 56: 848-53. PMID 12884891 DOI: 10.1001/archpsyc.56.9.848  0.32
1999 McPherson S, Back C, Buckwalter JG, Cummings JL. Gender-related cognitive deficits in Alzheimer's disease. International Psychogeriatrics / Ipa. 11: 117-22. PMID 11475426 DOI: 10.1017/S1041610299005670  0.32
1999 Ringman JM, Cummings JL. Metrifonate: update on a new antidementia agent. The Journal of Clinical Psychiatry. 60: 776-82. PMID 10584768  0.32
1999 Mendez MF, Ottowitz W, Brown CV, Cummings JL, Perryman KM, Mandelkern MA. Dementia with leukoaraiosis: clinical differentiation by temporoparietal hypometabolism on (18)FDG-PET imaging. Dementia and Geriatric Cognitive Disorders. 10: 518-25. PMID 10559569 DOI: 10.1159/000017199  0.32
1999 Di Patre PL, Read SL, Cummings JL, Tomiyasu U, Vartavarian LM, Secor DL, Vinters HV. Progression of clinical deterioration and pathological changes in patients with Alzheimer disease evaluated at biopsy and autopsy. Archives of Neurology. 56: 1254-61. PMID 10520942 DOI: 10.1001/archneur.56.10.1254  0.32
1999 Mendez MF, Perryman KM, Pontón MO, Cummings JL. Bilingualism and dementia. The Journal of Neuropsychiatry and Clinical Neurosciences. 11: 411-2. PMID 10440021  0.32
1999 van Gorp WG, Marcotte TD, Sultzer D, Hinkin C, Mahler M, Cummings JL. Screening for dementia: comparison of three commonly used instruments. Journal of Clinical and Experimental Neuropsychology. 21: 29-38. PMID 10420999 DOI: 10.1076/jcen.21.1.29.939  0.32
1999 Rummans TA, Lauterbach EC, Coffey CE, Royall DR, Cummings JL, Salloway S, Duffy J, Kaufer D. Pharmacologic efficacy in neuropsychiatry: a review of placebo-controlled treatment trials. A report of the ANPA Committee on Research. The Journal of Neuropsychiatry and Clinical Neurosciences. 11: 176-89. PMID 10333990  0.32
1999 Bartzokis G, Cummings JL, Markham CH, Marmarelis PZ, Treciokas LJ, Tishler TA, Marder SR, Mintz J. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magnetic Resonance Imaging. 17: 213-22. PMID 10215476 DOI: 10.1016/S0730-725X(98)00155-6  0.32
1999 Cummings JL. Managing psychosis in patients with Parkinson's disease. The New England Journal of Medicine. 340: 801-3. PMID 10072418 DOI: 10.1056/NEJM199903113401011  0.32
Show low-probability matches.